COMP <GO>
IH vs GHC // DIVIDEND YIELD & FCF PAYOUT SAFETY
iHuman Inc. each representing five (Class A) (NYSE) VS. Graham Holdings Company (NYSE) • 15-METRIC TALLY: IH 7
— GHC 4
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: IH
LAST: $1.18 (0.00%) • MKT CAP: $60.3M
dividend-safety
9.27%
LAST: $1,202.87 (+2.94%) • MKT CAP: $5.01B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IH VS. GHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IH | GHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 3.50% | +81.50 | IH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 3.2x | 18.1x | -14.90 | IH | /valuation <GO> |
| Free Cash Flow Yield | 12.17% | 5.59% | +6.58 | IH | /fcf-yield <GO> |
| Operating Margin | 8.30% | 4.80% | +3.50 | IH | /operating-margins <GO> |
| Net Profit Margin | 11.80% | 6.00% | +5.80 | IH | /net-margins <GO> |
| Revenue Growth (YoY) | -8.70% | 2.50% | -11.20 | GHC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 9.27% | 0.00% | +9.27 | IH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.30 | 3.05 | -0.75 | GHC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.6 | 57.3 | -4.70 | GHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 4.1x | 15.6x | -11.50 | IH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $60.3M | $5.01B | -$4.95B | GHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IH REV | GHC REV | IH GROSS % | GHC GROSS % | IH FCF | GHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $115.4M | $4.91B | 67.9% | — | $7.3M | $275.3M |
| FY 2024 | $126.3M | $4.79B | 69.4% | — | $8.0M | $324.1M |
| FY 2023 | $143.4M | $4.41B | — | — | $24.2M | $259.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IH // BETA —
GHC // BETA —